Last reviewed · How we verify

current insulin — Competitive Intelligence Brief

current insulin (current insulin) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Insulin. Area: Endocrinology / Diabetes.

marketed Insulin Insulin receptor Endocrinology / Diabetes Small molecule Live · refreshed every 30 min

Target snapshot

current insulin (current insulin) — Kinderkrankenhaus auf der Bult. Insulin replaces or supplements the body's own insulin to regulate blood glucose by promoting glucose uptake into cells and storage as glycogen.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
current insulin TARGET current insulin Kinderkrankenhaus auf der Bult marketed Insulin Insulin receptor
Tresiba INSULIN DEGLUDEC Novo Nordisk marketed Insulin Analog [EPC] Insulin receptor 2015-01-01
Levemir INSULIN DETEMIR Novo Nordisk marketed Insulin Analog [EPC] Insulin receptor 2005-01-01
Apidra INSULIN GLULISINE Sanofi marketed Insulin Analog [EPC] Insulin receptor 2004-01-01
Lantus INSULIN GLARGINE Sanofi marketed Insulin Analog [EPC] Insulin receptor 2000-01-01
Novolog INSULIN ASPART Novo Nordisk marketed Insulin Analog [EPC] Insulin receptor 2000-01-01
Humalog INSULIN LISPRO Eli Lilly marketed Insulin Analog [EPC] Insulin receptor 1996-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Insulin class)

  1. Eli Lilly and Company · 2 drugs in this class
  2. Hospital Universitario Dr. Jose E. Gonzalez · 2 drugs in this class
  3. Novo Nordisk A/S · 2 drugs in this class
  4. DreaMed Diabetes · 1 drug in this class
  5. Institute for Clinical and Experimental Medicine · 1 drug in this class
  6. Kinderkrankenhaus auf der Bult · 1 drug in this class
  7. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 drug in this class
  8. Mackay Memorial Hospital · 1 drug in this class
  9. Biodel · 1 drug in this class
  10. American Heart Association · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). current insulin — Competitive Intelligence Brief. https://druglandscape.com/ci/current-insulin. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: